2024/12/15 by Carol Hitchon, Hani El‐Gabalawy · 1 voice
Medicine · #Rheumatoid Arthritis Research and Therapies #Systemic Lupus Erythematosus Research #Autoimmune and Inflammatory Disorders Research
paper · pdf · doi:10.3899/jrheum.2024-1160
openalex publication_date 2024/12/15 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
It is now well established that if an individual exhibiting the clinical and serological features of early rheumatoid arthritis (RA) accesses appropriate and timely rheumatological care, the trajectory and outcome of this disease has dramatically improved over the last number of decades.<sup>1</sup> The availability of multiple pharmacological and nonpharmacological interventions, coupled with timely management strategies such as treat-to-target, has resulted in a substantial number of patients diagnosed with RA achieving remission or low disease activity at an early stage of their disease.